Untitled

Download a copy of this presentation.

Access the recording.

HealthTrust presents…“New Medications & FDA Updates 2017″

Program Summary
In 2017, there were 46 new molecular entities approved by the FDA for use in the United States as well as a number of FDA drug safety alerts. This presentation will review all the new medications that were approved by the FDA in 2017. A more comprehensive overview of the selection of the medications, as well as dosing and adverse effects, and a review of the studies
that lead to approval will be discussed. The end of the presentation will focus on FDA warnings that were published during 2017 and how they affect our practice.

Learning Objectives for Pharmacists  |  At the end of this session, participants should be able to:
1. List the medications that were brought to the market in 2017
2. Describe the indications and mechanisms of action of the new medications
3. Review adverse effects and patient safety information for these new medications
4. Relate new medications approved in 2017 with those approved previously with similar indications
5. Discuss important patient counseling and monitoring parameters for newly approved medications
6. Identify drug safety warnings that were published by the FDA in 2017

Learning Objectives for Pharmacy Techs  |  At the end of this session, participants should be able to:
1. List the medications that were brought to the market in 2017
2. Review appropriate storage instructions for the newly approved medications
3. Discuss unique preparation instructions for these new medications
4. Identify drug safety warnings that were published by the FDA in 2017

Presenter:

Suzannah Kokotajlo, PharmD  |  Pediatric Clinical Pharmacist  |  Goryeb Children’s Hospital  |  Morristown Medical Center

Target Audience: Pharmacists & Pharmacy Techs

Continuing Education information: This program is approved for CPEs by the Accreditation Council for Pharmacy Education (ACPE).
Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education
as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is  0863-0000-18-075-L01-P and 0863-0000-18-075-L01-T. The activity will provide 1 hour (.1 CEUs) of continuing education credit to pharmacists and technicians who attend the webinar and complete the online evaluation.

Note: No group credit is available. HealthTrust’s CE credit provider requires that each participant register and join the actual webinar event individually.